Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Anavex Lf SC (NQ: AVXL )

6.090 USD -0.190 (-3.03%)
Official Closing Price Updated: 7:48 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 460,300
Open 6.320
Bid (Size) 6.120 (8)
Ask (Size) 6.250 (5)
Prev. Close 6.280
Today's Range 6.050 - 6.360
52wk Range 2.200 - 7.690
Shares Outstanding 44,660,062
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73 (blarcamesine) in People with Parkinson’s Disease
From GlobeNewswire News Releases
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect Conference
From GlobeNewswire News Releases

Performance

YTD
+15.12%
+15.12%
1 Month
+8.17%
+8.17%
3 Month
+7.41%
+7.41%
6 Month
+37.47%
+37.47%
1 Year
+107.85%
+107.85%

More News

Read More
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates
From GlobeNewswire News Releases
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
From GlobeNewswire News Releases
Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data hosted by Ladenburg Thalmann & Co.
From GlobeNewswire News Releases
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
From GlobeNewswire News Releases
Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application with Expanding Claims Covering ANAVEX®2-73 (blarcamesine) for the Treatment of Rett Syndrome and other Neurodevelopmental
From GlobeNewswire News Releases
Implied FDM Analyst Target Price: $59
Tags ETFs
From ETF Channel
Anavex Life Sciences to Present at the Evercore ISI 3rd Annual HealthCONx Conference
From GlobeNewswire News Releases
First Week of March 19th Options Trading For Anavex Life Sciences (AVXL)
Tags Stocks
From Market News Video
Earnings Scheduled For December 28, 2020
Tags SECO Benzinga News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.